Biosimilars - Impact for Patients
In this webinar, Cate Lockhart - Executive Director at Biologics and Biosimilars Collective Intelligence Consortium, will help patients and families understand the...
In this webinar, Cate Lockhart - Executive Director at Biologics and Biosimilars Collective Intelligence Consortium, will help patients and families understand the...
In this webinar, Dr. Michael Pulsipher from Children's Hospital Los Angeles will discuss pediatric bone marrow transplant and how to optimize the best outcomes for...
In this webinar, Costa Herbert, RN from Fred Hutchinson Cancer Research Center will discuss the transplant process so patients and caregivers can travel the transplant...
In this webinar, Dr. Catherine Lai from MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center will discuss the challenges associated with...
Dr. Bart Scott from the Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center will discuss PNH and the biological role of the complement system in...
Dr. Scheinberg will discuss the history of Aplastic Anemia and give his insight into the future treatment options and ongoing research into this disease.
In this webinar, Dr. Daniel Weisdorf from the University of Minnesota Clinical and Translational Science Institute will discuss what is a bone marrow transplant and...
During this webinar, Dr. Michael Burke from Children's Hospital of Wisconsin, will discuss refractory/relapsed AML, how it is diagnosed, affects on treatments and what...
During this webinar, Dr. Pamela Becker from Seattle Cancer Care Alliance and University of Washington School of Medicine will discuss the history of MDS - past,...
During this webinar, Dr. Gail Roboz from Weill Cornell, discuss the advances in MDS and AML research that was reported at the annual conferences of two major...
During this webinar, Dr. Shyamala Navada from Tisch Cancer Institute will discuss the history of PNH - past, current and future thinking of the disease and treatment...
In this webinar, Dr. Elie Traer from OHSU Knight Cancer Institute in Portland, OR will discuss what is refractory/relapsed AML, how it is diagnosed, affects on...
In this webinar, Dr. Marlise Luskin from Dana Farber Cancer Institute will define high-risk MDS versus low-risk MDS, impact for patients and what treatment options are...
In this webinar, Dr. Saurabh Chhabra from The Cancer Center at Froedtert Hospital in Wisconsin will discuss the latest advances in preventing and treating...
In this webinar, Dr. Melhem Solh from The Blood and Marrow Transplant Group of Georgia will discuss what is GVHD, how it is diagnosed, signs and symptoms, treatment...